biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Gene Therapies

<< Previous

Bullboard Posts

Next >>

Comment by MBT123on Sep 03, 2022 2:25am

146 Views

Post# 34939822

RE:RE:RE:RE:RE:RE:RE:RE:RE:Gene Therapies

How fast you flip the script once you weren't getting your pesos for "writing" is actually comical! Man to be so wrong on everything and still put out (mis)information is actually remarkable! The market has never lied unlike you! .15pennies..hahahaha You made out with a fortune at .30 pennies..Dr.R is really crushing it I feel the tingling in my chain jar!

<< Previous

Bullboard Posts

Next >>

Debt-free cannabis company set for next stage of growth